SCHEMBL27095031

SCHEMBL27095031

CCCC/C=C\CCCC(O)CC(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 4/20 0.67
▸ FFAR1 O14842 1/20 0.54
▸ FFAR4 Q5NUL3 1/20 0.54
▸ F7 P08709 2/20 0.52
▸ F3 P13726 2/20 0.52
▸ NFKB1 P19838 1/20 0.48
▸ NFKB2 Q00653 1/20 0.48
▸ RELA Q04206 1/20 0.48
▸ TERT O14746 3/20 0.47
▸ PTPN1 P18031 3/20 0.47
▸ PPARG P37231 3/20 0.47
▸ PPARD Q03181 3/20 0.47
▸ PPARA Q07869 3/20 0.47
▸ TOP1 P11387 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ BLM P54132 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ FABP4 P15090 2/20 0.47
▸ FAAH O00519 2/20 0.47
▸ GMNN O75496 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28751120 0.93 GPR84 (0.73) GPR84FFAR1FFAR4F7F3
SCHEMBL28751122 0.93 GPR84 (0.73) GPR84FFAR1FFAR4F7F3
SCHEMBL666659 0.93 GPR84 (0.73) GPR84FFAR1FFAR4F7F3
SCHEMBL4748994 0.93 GPR84 (0.73) GPR84FFAR1FFAR4F7F3
SCHEMBL19115110 0.93 GPR84 (0.73) GPR84FFAR1FFAR4F7F3
SCHEMBL6333258 0.93 GPR84 (0.61) GPR84FFAR1FFAR4F7F3
SCHEMBL6333257 0.93 GPR84 (0.61) GPR84FFAR1FFAR4F7F3
SCHEMBL9457258 0.89 GPR84 (0.79) GPR84FFAR1FFAR4F7F3
SCHEMBL8603623 0.89 GPR84 (0.79) GPR84FFAR1FFAR4F7F3
SCHEMBL9456908 0.89 GPR84 (0.79) GPR84FFAR1FFAR4F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240172746-A1 NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES BASF SE (DE) 2024-05-30 — — US disclosed
US-20240058782-A1 New Microcapsules Containing Active Substances BASF SE (DE) 2024-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240058782-A1 New Microcapsules Containing Active Substances PLA2G2C, PHOSPHO1, PSPH GPR84 4197/4885FFAR1 4076/4885FFAR4 4517/4885
US-20240172746-A1 NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES SGMS1, SGMS2, LIPA GPR84 1914/4885FFAR1 277/4885FFAR4 722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback